Author | Matthew Davids, MD | OncLive

Author | Matthew Davids, MD

Articles

Dr. Davids Discusses Duvelisib Plus FCR in Young Patients With CLL

June 16, 2018

Video

Matthew Davids, MD, MMSc, associate director, Center for Chronic Lymphocytic Leukemia, Dana-Farber Cancer Institute, discusses duvelisib plus fludarabine-cyclophosphamide-rituximab (FCR) as a frontline therapy for the treatment of younger patients with chronic lymphocytic leukemia.

Dr. Matthew Davids On Advances in CLL

February 18, 2015

Video

Matthew Davids, MD, physician, Dana-Farber Cancer Institute, instructor in medicine, talks about advances in chronic lymphocytic leukemia (CLL) treatment.

x